The energy metabolism of RIF-1 tumours following hydralazine
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 19 (3) , 281-291
- https://doi.org/10.1016/0167-8140(90)90155-p
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Enhancement of the anti-tumor effect of melphalan in experimental mice by some vaso-active agentsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumorInternational Journal of Radiation Oncology*Biology*Physics, 1986
- The Effect of Several Different Anaesthetics on the Blood Pressure and Heart Rate of the Mouse and on the Radiation Response of the Mouse Sarcoma RIF-1International Journal of Radiation Biology, 1985
- Abnormal Response of Tumor Vasculature to Vasoactive Drugs23JNCI Journal of the National Cancer Institute, 1984
- Theoretical feasibility of vasodilator-enhanced local tumor heatingEuropean Journal of Cancer and Clinical Oncology, 1982
- Mapping of metabolites in whole animals by 31P NMR using surface coilsNature, 1980
- Development of the vascular system in the hamster malignant neurilemmomaMicrovascular Research, 1973
- Changes of Oxygen Tension in Tumours Induced by Vasoconstrictor and Vasodilator DrugsActa Radiologica, 1962